TABLE 3.
Comparison of COVID‐19 versus non‐COVID‐19 STEMI patients who underwent percutaneous coronary diagnostic and treatment in Poland
| Variable | Measure/levels | Non‐COVID‐19 | COVID‐19 | p |
|---|---|---|---|---|
| n | 2,276 | 145 | ||
| Age, years | Mean (±SD) | 65.43 (±12.23) | 63.19 (±12.55) | .0332* |
| Gender | n | 2,260 | 143 | .3570 |
| Female | 731 (32.35%) | 41 (28.67%) | ||
| Male | 1,529 (67.65%) | 102 (71.33%) | ||
| Diabetes mellitus | n | 2,278 | 145 | .4496 |
| 1 | 384 (16.86%) | 21 (14.48%) | ||
| Previous stroke | n | 2,278 | 145 | .8516 |
| 1 | 69 (3.03%) | 4 (2.76%) | ||
| Previous MI | n | 2,278 | 145 | .2449 |
| 1 | 363 (15.94%) | 18 (12.41%) | ||
| Previous PCI | n | 2,278 | 145 | .1550 |
| 1 | 400 (17.56%) | 19 (13.10%) | ||
| Previous CABG | n | 2,278 | 145 | .0844 |
| 1 | 24 (1.05%) | 0 (0.00%) | ||
| Smoking | n | 2,278 | 145 | .1265 |
| 1 | 708 (31.08%) | 54 (37.24%) | ||
| Hypertension | n | 2,278 | 145 | .0078 |
| 1 | 1,311 (57.55%) | 67 (46.21%) | ||
| Chronic kidney disease | n | 2,278 | 145 | .5952 |
| 1 | 75 (3.29%) | 6 (4.14%) | ||
| COPD | n | 2,278 | 145 | .2986 |
| 1 | 61 (2.68%) | 2 (1.38%) | ||
| Killip class | n | 1,756 | 124 | .2357 |
| 1 | 1,446 (82.35%) | 98 (79.03%) | ||
| 2 | 190 (10.82%) | 12 (9.68%) | ||
| 3 | 42 (2.39%) | 7 (5.65%) | ||
| 4 | 78 (4.44%) | 7 (5.65%) | ||
| Arterial access site | N | 2,055 | 143 | .0388* |
| Other | 15 (0.73%) | 2 (1.40%) | ||
| Radial left | 241 (11.73%) | 12 (8.39%) | ||
| Radial right | 1,501 (73.04%) | 96 (67.13%) | ||
| Femoral | 298 (14.50%) | 33 (23.08%) | ||
| Angiography finding | n | 2,055 | 143 | .4308 |
| No critical lesions | 58 (2.82%) | 4 (2.80%) | ||
| No atherosclerosis | 21 (1.02%) | 2 (1.40%) | ||
| Single vessel disease | 940 (45.74%) | 60 (41.96%) | ||
| Multivessel disease | 914 (44.48%) | 63 (44.06%) | ||
| Multivessel disease with LMCA | 116 (5.64%) | 12 (8.39%) | ||
| LMCA only | 6 (0.29%) | 2 (1.40%) | ||
| Time from pain to FMC, min | n | 1,618 | 105 | .8922 |
| Mean (±SD) | 226.77 (±282.07) | 249.13 (±306.70) | ||
| Mean 95% CI | (213.02; 240.53) | (189.78; 308.49) | ||
| Time from pain to inflation or angiogram, min | n | 1,560 | 101 | .1338 |
| Mean (±SD) | 309.90 (±279.09) | 354.33 (±313.35) | ||
| Mean 95% CI | (296.04; 323.76) | (292.47; 416.19) | ||
| Time from FMC to inflation or angiogram, min | n | 1,710 | 123 | .0323* |
| Mean (±SD) | 111.57 (±133.46) | 141.08 (±179.11) | ||
| Mean 95% CI | (105.24; 117.90) | (109.11; 173.05) | ||
| Death during procedure | n | 2,278 | 145 | .0441* |
| 1 | 26 (1.14%) | 5 (3.45%) | .0345* | |
| No‐reflow during PCI | n | 2,160 | 136 | .3522 |
| 1 | 36 (1.67%) | 1 (0.74%) | .7223 | |
| Bleeding at the puncture site during PCI | n | 2,160 | 136 | .6211 |
| 1 | 2 (0.09%) | 0 (0.00%) | 1.0000 |
*
p<.05 was considered meaningful.